FOCUS ASSET MANAGEMENT
VC Fund
Yeoksamdong, South Korea
FOCUS ASSET MANAGEMENT is a VC fund in Yeoksamdong focused on Health Care and Biotechnology. FOCUS ASSET MANAGEMENT provides recruiting and investment advisory services.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries FOCUS ASSET MANAGEMENT invests in
Stages FOCUS ASSET MANAGEMENT invests in
Countries FOCUS ASSET MANAGEMENT invests in
Investment Focus
Industry
- Health Care 2 (50%)
- Biotechnology 2 (50%)
- Medical 1 (25%)
- Genetics 1 (25%)
- Software 1 (25%)
Stage
- Series C 1 (25%)
- Funding Round 1 (25%)
- Post-IPO Equity 1 (25%)
- Convertible Note 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Neurophet is a medical technology enterprise that focuses on neuro-engineering and brain health. The company develops software programs that utilize artificial intelligence for the analysis of medical brain images. The firm creates simulation tools specifically for medical researchers and doctors who perform non-invasive electrical brainstimulation procedures. These applications allow medical professionals to generate three-dimensional models of individual human brains directly from magnetic resonance imaging data. | $10.8M / Post-IPO Equity / Apr 10, 2026 | ||
| AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden. | $15.4M / Convertible Note / Sep 29, 2022 | ||
| Bertis is the AI-Driven proteomics for the Next Era of Precision Medicine. Bertis platform utilises molecular diagnostics to identify cancer-related biomarkers, enabling medical practitioners to detect diseases. | $11.9M / Dec 28, 2020 | ||
| Bertis is the AI-Driven proteomics for the Next Era of Precision Medicine. Bertis platform utilises molecular diagnostics to identify cancer-related biomarkers, enabling medical practitioners to detect diseases. | $14.6M / Series C / Dec 28, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does FOCUS ASSET MANAGEMENT invest in?
FOCUS ASSET MANAGEMENT invests primarily in Health Care, Biotechnology and Medical startups, most often at Series C and Funding Round stage. Most of the 4 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did FOCUS ASSET MANAGEMENT last invest?
The most recent investment recorded for FOCUS ASSET MANAGEMENT closed in Apr 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!